Qinghai Ji

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 11, 2026

Integrated multi-omics and single-cell analyses identify metabolic heterogeneity and therapeutic vulnerabilities in medullary thyroid cancer.

Integrated multi-omics and single-cell analyses identify metabolic heterogeneity and therapeutic vulnerabilities in medullary thyroid cancer.

Journal: British journal of cancer

Published: October 29, 2025

A Phase II study of SHR-A1921, a TROP2-targeted antibody-drug conjugate, in patients with recurrent or metastatic salivary gland carcinoma.

A Phase II study of SHR-A1921, a TROP2-targeted antibody-drug conjugate, in patients with recurrent or metastatic salivary gland carcinoma.

Journal: NPJ precision oncology

Published: October 15, 2025

Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer.

Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer.

Journal: Cell reports. Medicine

Published: August 04, 2025

Updated Thresholds of Basal Calcitonin Level and Extent of Lymph Node Metastasis in Initially Treated Medullary Thyroid Cancer.

Updated Thresholds of Basal Calcitonin Level and Extent of Lymph Node Metastasis in Initially Treated Medullary Thyroid Cancer.

Journal: JAMA otolaryngology-- head & neck surgery

Published: June 26, 2025

Developing a thyroid cancer differentiation state classification system using deep residual networks and metabolic signature profiling.

Developing a thyroid cancer differentiation state classification system using deep residual networks and metabolic signature profiling.

Journal: NPJ digital medicine

Published: March 26, 2025

Clinical characteristics and outcomes of patients with intrathyroidal thymic carcinoma (ITC): a retrospective cohort study.

Clinical characteristics and outcomes of patients with intrathyroidal thymic carcinoma (ITC): a retrospective cohort study.

Journal: Gland surgery

Published: January 09, 2025

Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer.

Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 23, 2024

Decoding lymph node skip metastasis: impact on long-term outcomes in stage T1 papillary thyroid carcinoma.

Decoding lymph node skip metastasis: impact on long-term outcomes in stage T1 papillary thyroid carcinoma.

Journal: European journal of endocrinology

Published: September 04, 2024

Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study.

Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: August 17, 2024

Thyroid-stimulating hormone suppression in low-risk papillary thyroid cancer: a large-scale retrospective analysis of real-world data.

Thyroid-stimulating hormone suppression in low-risk papillary thyroid cancer: a large-scale retrospective analysis of real-world data.

Journal: EClinicalMedicine

Published: August 10, 2024

Revised Perspective on the AJCC Staging System for Medullary Thyroid Cancer: A Study of Two Nationwide Cohorts.

Revised Perspective on the AJCC Staging System for Medullary Thyroid Cancer: A Study of Two Nationwide Cohorts.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: July 03, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026